Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Blood|August 14, 2020
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphomaPier Luigi Zinzani, Ian W Flinn, Sam L S Yuen, et al.
Blood Advances|January 11, 2024
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective studyChiara Pagani, Chiara Rusconi, Alessia Dalla Pria, et al.
Haematologica|March 25, 2014
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scaleAndrea Gallamini, Sally F Barrington, Alberto Biggi, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Hematological Oncology|May 2, 2020
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantationAndrés J M Ferreri, Marianna Sassone, Piera Angelillo, et al.
Leukemia & Lymphoma|January 11, 2025
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVDChiara Rusconi, Angelica Barone, Andrea Visentin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 StudyPier Luigi Zinzani, Alessandro Broccoli, Daniela Maria Gioia, et al.
The Lancet. Haematology|August 7, 2018
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysisMassimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, et al.
The Oncologist|December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell LymphomasMichele Merli, Marco Frigeni, Laurent Alric, et al.
Blood|July 5, 2022
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapseChiara Rusconi, Chan Y Cheah, Toby A Eyre, et al.
Pageof 6